Glucagon-like peptide 1 receptor  (Protein)

(3S,9S,12S,15S,18S)-18-((6S,12S,15S,18S,21S,24S,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-sec-butyl-35-carboxy-6-(carboxymethylcarbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-ylcarbamoyl)-3-((2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,35S,41S)-41-amino-26-benzyl-35-(2-carboxyethyl)-17-(carboxymethyl)-5-(4-hydroxybenzyl)-23,29-bis((R)-1-hydroxyethyl)-8,11,20-tris(hydroxymethyl)-42-(1H-imidazol-4-yl)-2-isobutyl-14-isopropyl-38,38-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazadotetracontanamido)-9-(3-amino-3-oxopropyl)-12,15-dimethyl-4,7,10,13,16,24-hexaoxo-5,8,11,14,17,23-hexaazatetracontane-1,40-dicarboxylic acid bioactivity Glucagon-like peptide 1 receptor

US9175003, 428 bioactivity Glucagon-like peptide 1 receptor

(2S,5S,8S,11S,14S,20S)-2-((S)-1-((S)-1-((2S,5S,8S,11S,20S)-11-((6S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S,45S)-21-((1H-indol-3-yl)methyl)-1,48-diamino-6-(2-amino-2-oxoethylcarbamoyl)-12,36-bis(4-aminobutyl)-30-benzyl-27-sec-butyl-33-(2-carboxyethyl)-1-imino-18-isobutyl-15-isopropyl-24,39,42-trimethyl-8,11,14,17,20,23,26,29,32,35,38,41,44,48-tetradecaoxo-2,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazaoctatetracontan-45-ylcarbamoyl)-8-(2-carboxyethyl)-2-(4-hydroxybenzyl)-5-isobutyl-3,6,9,14,21-pentaoxo-1,4,7,10,15-pentaazacyclohenicosan-20-ylamino)-3-hydroxy-1-oxopropan-2-ylamino)-3-methyl-1-oxobutan-2-ylcarbamoyl)-20-((S)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)propanamido)-11-benzyl-8,14-bis((R)-1-hydroxyethyl)-5-(hydroxymethyl)-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazadocosane-1,22-dicarboxylic acid bioactivity Glucagon-like peptide 1 receptor

Liraglutide bioactivity Glucagon-like peptide 1 receptor

Glucagon like peptide-1 (GLP-1) analogue bioactivity Glucagon-like peptide 1 receptor

(3S,6S,9S,12S,15S,18S,21S,27S,30S,33S,36S,39S)-3-((3S,6S,9S,12S)-1-((2S,5S,8S,11S)-2-((1H-imidazol-5-yl)methyl)-8-(2-carboxyethyl)-5-methyl-3,6,9,14-tetraoxo-1,4,7,10-tetraazacyclotetradecan-11-yl)-6-benzyl-3,9-bis((R)-1-hydroxyethyl)-12-(hydroxymethyl)-1,4,7,10-tetraoxo-2,5,8,11-tetraazatridecanamido)-39-((6S,12S,15S,18S,21S,24S,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-6-(2-amino-2-oxoethylcarbamoyl)-12-(4-aminobutyl)-27-sec-butyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-ylcarbamoyl)-27-(3-amino-3-oxopropyl)-36-(4-aminobutyl)-21-(2-carboxyethyl)-15-(4-hydroxybenzyl)-9,12-bis(hydroxymethyl)-18-isobutyl-6-isopropyl-30,33-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxo-5,8,11,14,17,20,23,26,29,32,35,38-dodecaazadotetracontane-1,42-dioic acid bioactivity Glucagon-like peptide 1 receptor

(4S,7S,10S,13S,16S,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,58S)-4-((6S,12S,15S,18S,21S,24S,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-6-(2-amino-2-oxoethylcarbamoyl)-12-(4-aminobutyl)-27-sec-butyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-ylcarbamoyl)-58-((S)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)propanamido)-16-(3-amino-3-oxopropyl)-7-(4-aminobutyl)-49-benzyl-22-(2-carboxyethyl)-40-(carboxymethyl)-28,34-bis(4-hydroxybenzyl)-46,52-bis((R)-1-hydroxyethyl)-31,43-bis(hydroxymethyl)-25-isobutyl-37-isopropyl-10,13-dimethyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-octadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-octadecaazahenhexacontane-1,61-dioic acid bioactivity Glucagon-like peptide 1 receptor

(3S,6S,9R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S)-3-((2S,5S,8S,11S,14S,17S,20S,23S,24R)-11-((1H-indol-3-yl)methyl)-20-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-23-carbamoyl-24-hydroxy-14-isobutyl-5-isopropyl-17-(2-(methylthio)ethyl)-3,6,9,12,15,18,21-heptaoxo-1-phenyl-4,7,10,13,16,19,22-heptaazapentacosan-2-ylcarbamoyl)-39-((2S,5S,8S,11S,17S,20S,23S)-23-amino-17-(3-amino-3-oxopropyl)-8-benzyl-5,11-bis((R)-1-hydroxyethyl)-2,20-bis(hydroxymethyl)-24-(1H-imidazol-5-yl)-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazatetracosanamido)-6-(3-amino-3-oxopropyl)-30-(4-aminobutyl)-21-(carboxymethyl)-12,15-bis(3-guanidinopropyl)-27,36-bis(4-hydroxybenzyl)-18,33-bis(hydroxymethyl)-24-isobutyl-9-(mercaptomethyl)-5,8,11,14,17,20,23,26,29,32,35,38-dodecaoxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaazahentetracontane-1,41-dioic acid bioactivity Glucagon-like peptide 1 receptor

(3S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,45S,48S,51S,54S,81S)-54-((6S,12S,15S,18S,21S,24S,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-sec-butyl-35-carboxy-6-(carboxymethylcarbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-ylcarbamoyl)-3-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-2-methylpropanamido)-45-(3-amino-3-oxopropyl)-12-benzyl-39-(2-carboxyethyl)-21-(carboxymethyl)-33-(4-hydroxybenzyl)-9,15-bis((R)-1-hydroxyethyl)-18,27,30-tris(hydroxymethyl)-36-isobutyl-24-isopropyl-48,51-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,60,69,78,83-henicosaoxo-62,65,71,74-tetraoxa-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,59,68,77,82-henicosaazatrinonacontane-1,81,93-tricarboxylic acid bioactivity Glucagon-like peptide 1 receptor

(4S,7S,10S,13S,16S,22S,25S,28S,31S,34S,37S,40S,43S,46S,49S,52S,58S)-4-((6S,12S,15S,18S,21S,24S,27S,30S)-21-((1H-indol-3-yl)methyl)-1-amino-6-((2R)-1-amino-3-(1-(11-carboxyundecyl)-2,5-dioxopyrrolidin-3-ylthio)-1-oxopropan-2-ylcarbamoyl)-12-(4-aminobutyl)-27-sec-butyl-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29-octaoxo-31-phenyl-2,7,10,13,16,19,22,25,28-nonaazahentriacontan-30-ylcarbamoyl)-58-(2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)acetamido)-16-(3-amino-3-oxopropyl)-7-(4-aminobutyl)-49-benzyl-22-(2-carboxyethyl)-40-(carboxymethyl)-28-(4-hydroxybenzyl)-46,52-bis((R)-1-hydroxyethyl)-31,34,43-tris(hydroxymethyl)-25-isobutyl-37-isopropyl-10,13-dimethyl-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-octadecaoxo-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-octadecaazahenhexacontane-1,61-dioic acid bioactivity Glucagon-like peptide 1 receptor